title: Iseganan failure due to the wrong pharmaceutical technology.
authors.forename: Hendrik
authors.initials: H
authors.lastname: van Saene
authors.forename: Joris
authors.initials: J
authors.lastname: van Saene
authors.forename: Luciano
authors.initials: L
authors.lastname: Silvestri
authors.forename: Miguel
authors.initials: M
authors.lastname: de la Cal
authors.forename: Richard
authors.initials: R
authors.lastname: Sarginson
authors.forename: Durk
authors.initials: D
authors.lastname: Zandstra
mesh_terms: D023181:Antimicrobial Cationic Peptides; D006801:Humans; D009960:Oropharynx / Q000382:microbiology; D010455:Peptides / Q000008:administration & dosage*; D053717:Pneumonia, Ventilator-Associated / Q000188:drug therapy* / Q000382:microbiology*; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D017211:Treatment Failure
chemical_list: D023181:Antimicrobial Cationic Peptides; D010455:Peptides; C119872:antimicrobial peptide IB-367